FABP4 and obesity due to melanocortin 4 receptor deficiency: Emerging evidences suggest that A-FABP plays an important role in lipid-mediated biological processes, and is closely associated with obesity, diabetes, the metabolic syndrome, and the development of atherosclerosis [4]–[7].